LISTEN
Schultz: Businesses need to do more to help people
Yahoo Finance's Julia La Roche sits down with executive chairman and former CEO of Starbucks Howard Schultz
| Previous Close | 22.32 |
| Open | 22.30 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 22.30 - 22.32 |
| 52 Week Range | 18.25 - 22.39 |
| Volume | 1,100 |
| Avg. Volume | 1,237 |
| Net Assets | 14.34M |
| NAV | 22.06 |
| PE Ratio (TTM) | 262.59 |
| Yield | 3.71% |
| YTD Return | 17.34% |
| Beta (3y) | 0.90 |
| Expense Ratio (net) | 0.30% |
| Inception Date | 2002-11-13 |
- Market Realist•5 days ago
How Is Novartis’s Lucentis Positioned after 1H17?
In 1H17, Novartis’s (NVS) Lucentis reported revenues of around $922 million, which is a ~1% decline on a year-over-year (or YoY) basis.
- Market Realist•9 days ago
How TEVA’s Respiratory Franchise Is Positioned after 1H17
In 1H17, Teva Pharmaceutical's (TEVA) respiratory franchise reported revenues of ~$626 million, or ~8% lower YoY (year-over-year).
- Market Realist•19 days ago
AstraZeneca’s Segment-Wise Performance in 2Q17
At constant exchange rates, AstraZeneca reported an 8% decline in its product sales of ~$4.9 billion during 2Q17.
